Evidence map›Paper›PMID 24435677›Full record

ArticleEuropean journal of immunology2014

Expansion of Foxp3(+) T-cell populations by Candida albicans enhances both Th17-cell responses and fungal dissemination after intravenous challenge.

Natasha Whibley, Donna M Maccallum, Mark A Vickers, Sadia Zafreen, Herman Waldmann, Shohei Hori, Sarah L Gaffen, Neil A R Gow, Robert N Barker, Andrew M Hall

Open access · hybridAbstract read
In one paragraph

Article in European journal of immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 60 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Microbiology and molecular biology reviews : MMBR · 2024
    Review
  6. Article
  7. Candidiasis in breast cancer: Tumor progression or not?Iranian journal of basic medical sciences · 2024
    Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Journal of fungi (Basel, Switzerland) · 2021
    Article
  13. Immunopathogenesis of EmergingJournal of fungi (Basel, Switzerland) · 2021
    Article
  14. Article
  15. Article
  16. Emerging patterns of regulatory T cell function in tuberculosis.Clinical and experimental immunology · 2020
    Review
  17. Review
  18. Article
  19. Review
  20. Tumor Necrosis Factor and Regulatory T Cells.Yonsei medical journal · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Natasha WhibleyDivision of Applied Medicine, University of Aberdeen, Aberdeen, UK; Aberdeen Fungal Group, University of Aberdeen, Aberdeen, UK; Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, USA.
Donna M Maccallum
Mark A Vickers
Sadia Zafreen
Herman Waldmann
Shohei Hori
Sarah L Gaffen
Neil A R Gow
Robert N Barker
Andrew M Hall
University of Aberdeen · GBUniversity of Pittsburgh · USNHS Grampian · GBRIKEN Center for Integrative Medical Sciences · JPScottish National Blood Transfusion Service · GBUniversity of Oxford · GB

Funding

Host and Fungal Regulation of Type 17 Immunity to Oral CandidiasisR37DE022550 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Sarah L Gaffen · 2017 to 2026
$5.6M
IL-17 Receptor Signaling in the Oral MucosaR01DE022550 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GAFFEN, SARAH L · 2012 to 2016
$2.1M
IL-23/STAT3-Driven Oral Immune Responses to Candida albicansR01DE023815 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GAFFEN, SARAH L · 2014 to 2018
$1.9M
Biotechnology and Biological Sciences Research CouncilNIDCR NIH HHS DE022550NIDCR NIH HHS R01 DE022550NIDCR NIH HHS R01 DE023815NIDCR NIH HHS R37 DE022550Wellcome TrustWellcome Trust 080088Wellcome Trust 086827
6 · The paper itself

Abstract

Candida albicans remains the fungus most frequently associated with nosocomial bloodstream infection. In disseminated candidiasis, the role of Foxp3(+) regulatory T (Treg) cells remains largely unexplored. Our aims were to characterize Foxp3(+) Treg-cell activation in a murine intravenous challenge model of disseminated C. albicans infection, and determine the contribution to disease. Flow cytometric analyses demonstrated that C. albicans infection drove in vivo expansion of a splenic CD4(+) Foxp3(+) population that correlated positively with fungal burden. Depletion from Foxp3(hCD2) reporter mice in vivo confirmed that Foxp3(+) cells exacerbated fungal burden and inflammatory renal disease. The CD4(+) Foxp3(+) population expanded further after in vitro stimulation with C. albicans antigens (Ags), and included at least three cell types. These arose from proliferation of the natural Treg-cell subset, together with conversion of Foxp3(-) cells to the induced Treg-cell form, and to a cell type sharing effector Th17-cell characteristics, expressing ROR-γt, and secreting IL-17A. The expanded Foxp3(+) T cells inhibited Th1 and Th2 responses, but enhanced Th17-cell responses to C. albicans Ags in vitro, and in vivo depletion confirmed their ability to enhance the Th17-cell response. These data lead to a model for disseminated candidiasis whereby expansion of Foxp3(+) T cells promotes Th17-cell responses that drive pathology.

Indexed as

Cell ProliferationAnimalsCandida albicansCandidiasisCells, CulturedCytokinesFlow CytometryForkhead Transcription FactorsHost-Pathogen InteractionsInterleukin-2 Receptor alpha SubunitKidney DiseasesMiceMice, Inbred C57BLSpleenTh17 CellsT-Lymphocytes, RegulatoryCytokinesForkhead Transcription FactorsFoxp3 protein, mouseInterleukin-2 Receptor alpha SubunitCandida albicansDisseminated infectionFoxp3Regulatory T (Treg) cellTh17

Identifiers

PMID24435677
PMCPMC3992851
OpenAlexW2130226038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.